Stock-Based Compensation (Details Narrative) - USD ($)												12 Months Ended
	Nov. 28, 2015	Sep. 14, 2015	Oct. 07, 2014	Jul. 15, 2014	Jun. 26, 2014	Jan. 28, 2014	Dec. 24, 2013	Sep. 16, 2012	Oct. 05, 2011	Oct. 15, 2009	Jun. 20, 2007	Dec. 31, 2015	Dec. 31, 2014	Oct. 07, 2015	Jun. 24, 2015	Apr. 07, 2015	Feb. 28, 2015	Jan. 28, 2015	Jun. 24, 2014
Options exercisable period												2 years 7 months 24 days
Options, exercisable price per share												$ 0.586	$ 0.626
Stock price per share													$ 0.24
Services cost												$ 52,625
Fair value of warrants												$ 34,016	$ 302,691
Fair market value, per share												$ 0.296	$ 0.24
Stock based compensation												$ 549,697	$ 946,175
Total deferred compensation expense for outstanding value of unvested stock options												264,000
Intrinsic value of exercisable but unexercised in-the-money stock options												$ 31,300	$ 2,750
Outstanding options to acquire common stock non-vested												1,150,000
ProActive Capital Resources Group LLC [Member]
Stock options granted to purchase common stock			125,000
Number of stock options available for issuance			250,000
Options exercisable period			1 year
Options, exercisable price per share			$ 0.25
Options vest			125,000										125,000			125,000
Stock price per share			$ 0.066
Charges to operations													$ 45,500
Services cost			$ 1,500									$ 13,500	12,000
Fair value of warrants			$ 33,000
Issuance of warrants to purchase of common stock			500,000
Fair value of common stock grants													12,500
Operations for the aggregate fair value of these securities													76,750
Gil Schwartzberg [Member]
Stock options granted to purchase common stock									500,000	500,000
Number of stock options available for issuance																	500,000
Options, exercisable price per share									$ 1.00	$ 1.00
Options, fair value				$ 1,000,000
Stock price per share				$ 0.04
Stock option expiration date									Oct. 05, 2016	Oct. 15, 2014
Fair value of warrants				$ 43,500
Francis Johnson [Member] | Chem-Master International, Inc [Member]
Options exercisable period					5 years
Options, exercisable price per share					$ 0.25
Options vest					500,000
Options, fair value					$ 118,650
Stock price per share					$ 0.24
Dr. Fritz Henn [Member]
Stock options granted to purchase common stock	200,000
Options exercisable period	5 years
Options, exercisable price per share	$ 0.50
Options vest	100,000
Stock price per share	$ 0.5168
Charges to operations												54,325
Options, vesting date	Nov. 28, 2016
Fair value of warrants	$ 103,360
Operations for the aggregate fair value of these securities	$ 51,680
Dr. Fritz Henn [Member] | November 28, 2016 [Member]
Options vest	100,000
Dr. Kathleen P. Mullinix [Member]
Stock options granted to purchase common stock								200,000
Options exercisable period								5 years
Options, exercisable price per share								$ 0.65
Options, fair value								$ 118,000
Stock price per share								$ 0.59
Charges to operations													$ 26,899
Options, vesting date								Jun. 16, 2014					Jun. 24, 2017
Andrew Robell [Member]
Options, exercisable price per share			$ 0.50
Options vest			100,000											100,000
Stock price per share			$ 0.10
Consulting Arrangements [Member]
Charges to operations												74,901	$ 732,699
Consulting Arrangements [Member]
Stock options granted to purchase common stock						4,000,000
Options exercisable period						5 years
Options, exercisable price per share						$ 0.50
Options vest						2,000,000												2,000,000
Options, fair value						$ 596,400
Stock price per share						$ 0.15
Charges to operations						$ 298,200
Options, vesting date						Jan. 28, 2015
NDA Agreement [Member]
Stock options granted to purchase common stock							100,000
Options exercisable period							5 years
Options, exercisable price per share							$ 0.13
Options vest															25,000				25,000
Options, fair value							$ 12,960
Stock price per share							$ 0.13
Charges to operations												9,189	8,901
Advisory Agreement [Member]
Charges to operations												$ 10,064	$ 15,526
2007 Stock Compensation Plan [Member]
Number of restricted stock issued											2,500,000
Stock options granted to purchase common stock												550,000
Number of stock options available for issuance												1,950,000
Immediate Vesting [Member] | Dr. Kathleen P. Mullinix [Member]
Options vest								25,000
Quarterly Vesting Thereafter [Member] | Dr. Kathleen P. Mullinix [Member]
Options vest								25,000
Vesting On June 24, 2016 [Member] | NDA Agreement [Member]
Options vest							25,000
Vesting On June 24, 2017 [Member] | NDA Agreement [Member]
Options vest							25,000
Andrew Robell [Member]
Stock options granted to purchase common stock			200,000
Options exercisable period			5 years
Options, fair value			$ 20,000
Vested [Member] | Andrew Robell [Member]
Options, fair value			$ 10,000
BioPharmaWorks LLC [Member]
Stock options granted to purchase common stock		1,000,000
Options exercisable period		5 years
Options, exercisable price per share		$ 0.26
Options, fair value		$ 260,000
Charges to operations												$ 324,468
Issuance of warrants to purchase of common stock		1,000,000
BioPharmaWorks LLC [Member] | First Warrant [Member] | September 14, 2016 [Member]
Options exercisable period												5 years
Stock price per share												$ 0.2568
Fair value of warrants												$ 128,400
Issuance of warrants to purchase of common stock												500,000
Fair market value, per share												$ 1.00
BioPharmaWorks LLC [Member] | Second Warrant [Member] | September 14, 2017 [Member]
Options exercisable period												5 years
Stock price per share												$ 0.2557
Fair value of warrants												$ 127,850
Issuance of warrants to purchase of common stock												500,000
Fair market value, per share												$ 2.00